The label expansion couls help J&J establish Tremfya as a successor to Stelara, which is now facing a growing biosimilar ...

Celex Oncology’s first attendance at Bio-Europe Spring 2025 follows their recent win at the 2024 EIT Health Catapult ...

Discover a study that compared the effectiveness of P043 versus omalizumab in managing uncontrolled allergic asthma.

In an alopecia areata trial, a novel bifunctional therapy that blocks signaling of the interleukin-7 and TSLP pathways ...

BEIJING, March 4 (Xinhua) -- China has initiated legal action against the United States under the World Trade Organization (WTO) dispute settlement mechanism regarding the latter's latest tariff ...

However, the underlying mechanism for spontaneous remission of gout requires further elucidation. In this article, we summarise the roles and mechanisms related to spontaneous remission of gout, which ...

In patients with antineutrophil cytoplasmic antibody (ANCA)-associated vasculitis (AAV ... Although MPO-ANCAs are known to be key molecules in the pathogenesis of AAV, the mechanisms involved in ...

bViral Epidemiology and Immunity Unit, Laboratory of Infectious Diseases, National Institute of Allergy and Infectious Diseases, National Institutes of Health, Bethesda, MD, USA cSealy Institute for ...

Advanced Merkel Cell Carcinoma Pipeline Outlook Tidutamab (previously XmAb18087) is a bispecific antibody that engages ... a different mechanism of action, and molecular type.

1 subvariants and nirmatrelvir/ritonavir was effective against Omicron BA.2/BA.4/BA.5 subvariants. Certain antiviral drugs and monoclonal antibody (mAb) therapies continue to lower mortality risk and ...